Commentary on "Use of pharmacodynamic endpoints for the evaluation of levofloxacin for the treatment of acute maxillary sinusitis" by Ambrose et al

Diagn Microbiol Infect Dis. 2008 May;61(1):21-2. doi: 10.1016/j.diagmicrobio.2008.02.007. Epub 2008 Mar 28.
No abstract available

Publication types

  • Comment
  • Letter
  • Multicenter Study

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Bacterial Infections / drug therapy*
  • Humans
  • Levofloxacin*
  • Maxillary Sinusitis / drug therapy*
  • Ofloxacin / therapeutic use*

Substances

  • Anti-Bacterial Agents
  • Levofloxacin
  • Ofloxacin